Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

I lose weight with zenso!!💯

I lose weight with zenso!!💯

Suggested For You

🔥✨ Wellous x Beauty in The Pot ✨🔥

🔥✨ Wellous x Beauty in The Pot ✨🔥

Wellous has teamed up with Beauty in The Pot to bring an exclusive treat to our beloved WellFam! 💖

🍲 Just spend RM350 and above at Beauty in The Pot and enjoy RM80 OFF instantly! 🥢🎉

It’s our way of serving you more joy, more flavor, and more savings — all in one pot! 😍

Gather your friends, bring your appetite, and let’s make every meal a feast to remember! 💚

WellFam Update!

WellFam Update!

We had an incredible experience giving back to the community by distributing essential food supplies and immersing ourselves in their traditions. Guided by Encik Jerri, we tried blow darts and learned how they use daun bertam to build roofs—truly eye-opening!

Despite modernization challenges, the Orang Asli’s knowledge of the land is unmatched—they even assist in search and rescue missions!

Sharing a meal made with bamboo shoots showed us their amazing resourcefulness. It was all about learning, connecting, and appreciating their resilient way of life!

Running late because of constipation, hiding from friends due to acne, or too shy to talk with your crush because of bad breath? 😳 It might be your gut signaling for help! Don't fret, SPI2RO is your gut hero! 🦸‍♂️ Get comfy with your gut and watch life get better. ✨💚

Running late because of constipation, hiding from friends due to acne, or too shy to talk with your crush because of bad breath? 😳 It might be your gut signaling for help! Don't fret, SPI2RO is your gut hero! 🦸‍♂️ Get comfy with your gut and watch life get better. ✨💚

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

我们最新一期的时事简报将带你深入探讨肝脏健康!本期的资讯内容涵盖了一系列常见的肝脏疾病,探索了预防病毒性肝炎和脂肪肝的方法,以及我们本期的重点产品 - LIVETAL 和 HOMEGA,为你的肝脏健康助力加持!还有,也别错过了试试我们这期的数字排毒挑战,让自己暂时“退出”数字世界,全面地身心放松!🧡✨

点击下方链接查看完整的时事简报,了解更多关于保持肝脏健康的知识吧!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-cn.pdf